STERIS plc (NYSE:STE) Receives Consensus Rating of “Moderate Buy” from Analysts

STERIS plc (NYSE:STEGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $241.60.

STE has been the topic of several research reports. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, May 9th. Piper Sandler restated a “neutral” rating and set a $225.00 price target (up previously from $220.00) on shares of STERIS in a research note on Friday, May 10th. StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research note on Friday. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, May 10th. Finally, Stephens reiterated an “overweight” rating and issued a $250.00 target price on shares of STERIS in a research note on Friday, February 9th.

Check Out Our Latest Report on STERIS

Insiders Place Their Bets

In other STERIS news, SVP Cary L. Majors sold 2,024 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares of the company’s stock, valued at $2,639,085.97. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other STERIS news, SVP Cary L. Majors sold 2,024 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares of the company’s stock, valued at $2,639,085.97. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $231.53, for a total value of $1,061,333.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,762 shares of company stock valued at $1,798,477. 0.95% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On STERIS

A number of institutional investors and hedge funds have recently modified their holdings of STE. Fenimore Asset Management Inc. lifted its holdings in STERIS by 13.1% in the fourth quarter. Fenimore Asset Management Inc. now owns 210,747 shares of the medical equipment provider’s stock valued at $46,333,000 after acquiring an additional 24,377 shares during the period. Cullen Investment Group LTD. acquired a new position in STERIS in the fourth quarter valued at approximately $1,351,000. Cerity Partners LLC lifted its holdings in STERIS by 5,199.4% in the fourth quarter. Cerity Partners LLC now owns 65,925 shares of the medical equipment provider’s stock valued at $14,494,000 after acquiring an additional 64,681 shares during the period. Financiere des Professionnels Fonds d investissement inc. lifted its holdings in STERIS by 12.9% in the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 45,095 shares of the medical equipment provider’s stock valued at $9,914,000 after acquiring an additional 5,168 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in STERIS by 4.8% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 976,402 shares of the medical equipment provider’s stock valued at $208,491,000 after acquiring an additional 44,781 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STERIS stock opened at $230.48 on Friday. The firm has a market cap of $22.79 billion, a P/E ratio of 60.34 and a beta of 0.85. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49. STERIS has a 12 month low of $195.47 and a 12 month high of $254.00. The stock’s fifty day moving average price is $216.88 and its 200-day moving average price is $218.85.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating the consensus estimate of $2.41 by $0.17. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.30 earnings per share. On average, equities research analysts expect that STERIS will post 9.27 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 0.90%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio is presently 54.45%.

STERIS Company Profile

(Get Free Report

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Recommended Stories

Analyst Recommendations for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.